An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy

Stopped early · Phase 3

Conditions studied: Duchenne Muscular Dystrophy

In brief

The main objective of this study is to evaluate the safety and tolerability of long-term treatment with casimersen or golodirsen in patients with Duchenne muscular dystrophy (DMD).

Key facts

Study ID
NCT03532542
Run by
Sarepta Therapeutics, Inc.
People needed
171
Starts
2018-08-02
Expected to finish
2023-07-26
Last updated by the study team
2024-09-19

Who can join

Age: 7 and older, up to 23. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.